Related Experiment Video
Updated: Jul 18, 2026

10:15
Isolation and Culture Expansion of Tumor-specific Endothelial Cells
Published on: October 14, 2015
Gene therapy targeting to tumor endothelium
M Bazan-Peregrino1, L W Seymour, A L Harris
1Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, Woodstock Road, Oxford, UK.
Cancer Gene Therapy
|November 11, 2006
Summary
Tumor vasculature offers a vulnerable target for cancer gene therapy. Targeting unique tumor blood vessel features can enhance gene delivery and anti-cancer effects.
Area of Science:
- Oncology
- Vascular Biology
- Gene Therapy
Background:
- Tumor vasculature is crucial for cancer survival and growth.
- It presents unique molecular targets distinct from normal vasculature.
- Hypoxia and angiogenesis significantly alter tumor blood vessel characteristics.
Purpose of the Study:
- To review strategies for targeting tumor vasculature in cancer gene therapy.
- To assess challenges and suitable vectors for gene delivery to tumor blood vessels.
- To highlight promising research areas in exploiting tumor vasculature as a therapeutic target.
Main Methods:
- Review of existing literature on tumor vasculature and gene therapy.
- Analysis of molecular differences between tumor and normal vasculature.
- Evaluation of gene delivery vectors and targeting strategies (transductional and transcriptional).
Main Results:
- Tumor vasculature exhibits distinct features like receptor overexpression and altered adhesion molecules.
- Transductional and transcriptional targeting offer tumor-selective gene delivery.
- Tumor vasculature is a key site for anti-angiogenic gene therapy action.
Conclusions:
- Targeting tumor vasculature is a promising strategy for cancer gene therapy.
- Overcoming challenges in gene delivery is essential for therapeutic success.
- Further research into novel vectors and targeting methods is warranted.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

